372 related articles for article (PubMed ID: 31479922)
1. Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.
Zhao Z; Ji M; Wang Q; He N; Li Y
Mol Ther Nucleic Acids; 2019 Dec; 18():24-33. PubMed ID: 31479922
[TBL] [Abstract][Full Text] [Related]
2. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
Li Z; Niu H; Qin Q; Yang S; Wang Q; Yu C; Wei Z; Jin Z; Wang X; Yang A; Chen X
Mol Ther Nucleic Acids; 2019 Sep; 17():92-101. PubMed ID: 31234009
[TBL] [Abstract][Full Text] [Related]
3. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
Zhao Y; Zheng R; Chen J; Ning D
Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer.
Wu H; Zhao X; Wang J; Jiang X; Cheng Y; He Y; Sun L; Zhang G
Front Genet; 2021; 12():815448. PubMed ID: 35154259
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
[TBL] [Abstract][Full Text] [Related]
6. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.
Chen H; Mao M; Jiang J; Zhu D; Li P
Onco Targets Ther; 2019; 12():3869-3879. PubMed ID: 31190886
[No Abstract] [Full Text] [Related]
8. Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.
Zhao Z; Ji M; Wang Q; He N; Li Y
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102213. PubMed ID: 38784178
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway.
Li X; Zheng Y; Zheng Y; Huang Y; Zhang Y; Jia L; Li W
Stem Cell Res Ther; 2018 Aug; 9(1):232. PubMed ID: 30170617
[TBL] [Abstract][Full Text] [Related]
10. The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression.
Geng HH; Li R; Su YM; Xiao J; Pan M; Cai XX; Ji XP
PLoS One; 2016; 11(3):e0151753. PubMed ID: 26998750
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 Reversed the PC12 Cell Damage Induced by circRNA CDR1as/miR-671/GSK3β Signaling Pathway.
Quan H; Chen Q; Wang K; Wang Q; Lu M; Zhang Y; Qiang S; Xue S; Han L; Zhu H; Fan Q; Bao M; Xu W; Wang W
J Mol Neurosci; 2021 Apr; 71(4):778-789. PubMed ID: 32889692
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.
Yang W; Gu J; Wang X; Wang Y; Feng M; Zhou D; Guo J; Zhou M
J Cell Mol Med; 2019 May; 23(5):3166-3177. PubMed ID: 30884120
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CircRNA CDR1as specifically triggered low-dose Diosbulbin-B induced gastric cancer cell death by regulating miR-7-5p/REGγ axis.
Li C; Li M; Xue Y
Biomed Pharmacother; 2019 Dec; 120():109462. PubMed ID: 31542615
[TBL] [Abstract][Full Text] [Related]
15. circRNA circARNT2 Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting the miR-155-5p/PDK1 Axis.
Li Y; Zhang Y; Zhang S; Huang D; Li B; Liang G; Wu Y; Jiang Q; Li L; Lin C; Wei Z; Meng L
Mol Ther Nucleic Acids; 2021 Mar; 23():244-254. PubMed ID: 33425483
[TBL] [Abstract][Full Text] [Related]
16. The Circular RNA CDR1as Regulates the Proliferation and Apoptosis of Human Cardiomyocytes Through the miR-135a/HMOX1 and miR-135b/HMOX1 Axes.
Chen C; Shen H; Huang Q; Li Q
Genet Test Mol Biomarkers; 2020 Sep; 24(9):537-548. PubMed ID: 32762552
[No Abstract] [Full Text] [Related]
17. Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma.
Zhong Q; Huang J; Wei J; Wu R
Cancer Cell Int; 2019; 19():252. PubMed ID: 31582908
[TBL] [Abstract][Full Text] [Related]
18. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
Zhang J; Hu H; Zhao Y; Zhao Y
Cell Prolif; 2018 Dec; 51(6):e12521. PubMed ID: 30182381
[TBL] [Abstract][Full Text] [Related]
19. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
Su Y; Lv X; Yin W; Zhou L; Hu Y; Zhou A; Qi F
Aging (Albany NY); 2019 Oct; 11(19):8183-8203. PubMed ID: 31581132
[TBL] [Abstract][Full Text] [Related]
20. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.
Yu L; Gong X; Sun L; Zhou Q; Lu B; Zhu L
PLoS One; 2016; 11(7):e0158347. PubMed ID: 27391479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
